Provided by Tiger Trade Technology Pte. Ltd.

Cardiff Oncology, Inc.

1.03
+0.03643.66%
Post-market: 0.9803-0.0497-4.83%19:30 EDT
Volume:838.85K
Turnover:868.07K
Market Cap:80.00M
PE:-1.74
High:1.07
Open:1.01
Low:1.00
Close:0.9936
52wk High:3.31
52wk Low:0.7566
Shares:77.67M
Float Shares:75.24M
Volume Ratio:1.67
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5914
EPS(LYR):-0.6863
ROE:-94.08%
ROA:-46.73%
PB:3.02
PE(LYR):-1.50

Loading ...

Cardiff Oncology announces annual shareholder meeting

Reuters
·
Apr 24

Cardiff Oncology to present updated onvansertib Phase 2 mCRC data at ASCO 2026

Reuters
·
Apr 21

Cardiff Oncology to present preclinical data on onvansertib

TIPRANKS
·
Apr 18

Cardiff Oncology reports preclinical onvansertib-T-DXd synergy in HER2-low breast cancer models

Reuters
·
Apr 18

Cardiff Oncology CFO Joshua Muntner files initial beneficial ownership statement

Reuters
·
Apr 17

BRIEF-Cardiff Oncology Announces Key Leadership Appointments To Strengthen Executive Team For Next Phase Of Growth

Reuters
·
Apr 10

Cardiff Oncology names Mani Mohindru CEO, appoints Josh Muntner CFO

Reuters
·
Apr 10

Cardiff Oncology Inc - Appoints Josh Muntner as CFO Effective April 6 and Ajay Aggarwal as COO Effective April 27

THOMSON REUTERS
·
Apr 10

Cardiff Oncology Inc - Appoints Mani Mohindru as President and CEO; to Continue as Board Member

THOMSON REUTERS
·
Apr 10

Cardiff Oncology CEO Mark Erlander resigns as director after stepping down as CEO

Reuters
·
Apr 03

These 16 stocks are a short seller's dream - likely losers no matter what the market does

Dow Jones
·
Mar 29

These 16 stocks are a short seller's dream - likely losers no matter what the market does

Dow Jones
·
Mar 27

Noble Financial Sticks to Its Buy Rating for Cardiff Oncology (CRDF)

TIPRANKS
·
Mar 27

Analysts Are Bullish on These Healthcare Stocks: Cardiff Oncology (CRDF), CSPC Pharmaceutical Group (CHJTF)

TIPRANKS
·
Mar 26

Cardiff Oncology to host KOL webinar on first-line RAS-mutated metastatic colorectal cancer

Reuters
·
Mar 20

Cardiff Oncology to present onvansertib and T-DXd preclinical data at AACR Annual Meeting 2026

Reuters
·
Mar 19